Sylvester Discusses Wave of Plaintiffs’ CBD-Level Lawsuits

07 October 2019 News

Special Counsel Brian Sylvester was quoted in the article, “Plaintiff’s Bar Turns Attention to CBD with Wave of Lawsuits Alleging Products Contain ‘Significantly Lower Levels’ Than Advertised,” about how the plaintiff’s bar has begun suing CBD product manufacturers over the level of CBD in their products. The suits claim that the CBD levels often are significantly lower than advertised on websites and labeling for the products.

Sylvester said the discrepancies were potentially a fertile ground for the plaintiff’s bar. “We’ve already heard from the FDA that as part of their regulatory enforcement activity (i.e., warning letters issues to firms that market unapproved new drugs that allegedly contain CBD), the FDA has tested the chemical content of cannabinoid compounds in some of the products, and many were found to not contain the levels of CBD they claimed to contain. Plaintiffs have taken note of these findings.”

Related Services


Will Other Tech Companies Join Microsoft in Honoring CCPA Across the U.S.?
18 November 2019
Internet, IT & e-Discovery Blog
Get Off My Lawn! Employers Gain Expanded Rights to Keep Unions Away from Their Property
18 November 2019
Labor & Employment Law Perspectives
Debunking Conventional Labor and Employment Wisdom
18 November 2019
Labor & Employment Law Perspectives
Racing to Innovate: The OESA’s 2019 Industry Outlook Panel
14 November 2019
Dashboard Insights
PATH Summit 2019
18-20 December 2019
Arlington, VA
Madison CLE Days
18-19 December 2019
Madison, WI
MedTech Impact Expo & Conference
13-15 December 2019
Las Vegas, NV
Review of 2020 Medicare Changes for Telehealth
11 December 2019
Member Call